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Abstract The membrane topology of a2/6 subunit was investi- 
gated utilizing electrophysiological functional assay and specific 
anti-a2 antibodies. (a) cRNA encoding a deleted a216 subunit 
was coinjected with a lC  subunit of the L-type calcium channel 
into Xenopus oocytes. The truncated form, lacking the third puta- 
tive TM domain (c~21~ATMIII), failed to amplify the expressed 
inward currents, normally induced by a~c coinjected with intact 
c~2/6 subunit. Western blot analysis of a216ATMIII shows the 
appearance of a degraded o~2 protein and no expression of the 
full-size two-TM truncated-protein. The improper processing of 
a2/6ATMIII suggests that the a216 is a single TM domain 
protein and the TM region is positioned at the 6 subunit. 
(b) External application of anti-a2 antibodies, prepared for an 
epitope within the alternatively spliced and 'intracellular' region, 
inhibits depolarization induced secretion in PC12, further sup- 
porting an external ocation of the a2 subunit and establishing 6 
subunit as the only membrane anchor for the extraceHular a2 
subunit. 
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1. Introduction 
Diverse types of voltage-activated Ca2+ channels have been 
identified of which L- and N-type have been isolated and their 
subunits described. The L-type consists of four different sub- 
units c~l, ~2/g, fl and y which have been characterized in detail 
for rabbit skeletal muscle (for reviews, see [1-6]). The N-type 
Ca 2+ channel consists of czl, c~2/~, and fl subunits and an addi- 
tional 95 kDa polypeptide [7] which is absent from the subunit 
composition of the L-type channel. 
Most attention has been focused on the functional ~1 subunit 
which introduces Ca 2+ across the cell membrane independently 
of the other auxiliary subunits [8,9]. The c~2/~-subunit is the 
largest integral component of purified voltage-sensitive Ca 2+ 
channels and the cDNA encoding the ~2/5 subunit was first 
cloned and sequenced from rabbit skeletal muscle [10] and later 
from rat brain [11] and human brain [12]. A single ~2/g precur- 
sor encodes two polypeptides, the c~2 and ~ [13]. A proteolytic 
cleavage site (Ala 934 Ala935), distinguishes between the two 
polypeptides which are connected by a disulfide bond [14]. The 
hydropathy plot predicts three putative TM segments [10]. This 
model was challenged by a biochemical study, suggesting a
single TM region in the 5-peptide, placing the c~2 peptide en- 
tirely in the extracellular domain [13]. Co-expression of ~2/5 
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subunit with c~lC (cardiac muscle) subunit in Xenopus oocytes 
increases inward current amplitude without affecting either the 
kinetics or the number of the channels expressed [15-18]. In 
addition, expression of ~1 is required for proper targeting and 
distribution of e2 subunit [19], and ~2/~ modulates the binding 
affinity of o)-CgTx to the N-type Ca 2+ channel [20]. No specific 
function has yet been associated with the ~2/~ subunit although 
the existence of five different spliced variants suggests a func- 
tional importance [20,21]. Recently, a single TM protein model 
for the ~2 subunit was proposed by the use of site directed 
antibodies [22]. 
We performed a deletion analysis of c~2/5 in order to study 
its interaction with the c~l subunit and to distinguish between 
the two proposed secondary structures. In addition, we have 
generated antibodies against an epitope within the extracellular 
region, according to the single TM model, and applied them to 
PC12 cells, monitoring their effect on the L-type Ca 2+ channel 
by measuring depolarization mediated secretion. 
2. Materials and methods 
Expression vector pQE-30 and Ni/NTA agarose were obtained from 
Qiagen, and pGEX-4T and glutathione-S-Sepharose 4B were obtained 
from Pharmacia LKB Biotechnology. The ECL detection kit for im- 
munoblotting was obtained from Amersham (UK). [3H]Dopamine 
from New England Nuclear US. All other eagents were obtained from 
commercial sources. 
2.1. Plasmid construction and cRNA syt, thesis in vitro 
Rabbit skeletal muscle ~2/~ subunit was obtained from Dr. A. 
Schwartz (Ohio, USA). 
2.1.1. Construction of truncated ct2/5 subunit. To create an in-frame 
deletion of the third putative transmembrane domain designated c~2/5 
ATMIII, the enzyme EcoRV was used to excise from the skeletal muscle 
c~2/~ clone a fragment of 332 bp at EeoRV site upstream to TMIII (nt 
347C~3473). At the 3' end, SpeI was used to cut at nt 3802-3805, 
downstream toTMIII and the end of the coding region. The truncated 
~2/5 was ligated to give a 332 bp shorter cDNA that was verified by 
cutting the original and the mutated plasmid with XbaI to yield a 600 
bp shorter fragment when compared with the original full length 
cDNA. ~z2/~ ATMIII was identical in all other respects (ATG site and 
poly(A)) to the original ~2/5 plasmid. The deletion resulted in the 
removal of 110 amino acids I lu 997 Leu ~°8° which included the third 
putative TM domain present in the ~ subunit. During the ligation 7 
amino acids were added at the carboxy-terminal end. The new deleted 
construct was transcribed to give the appropriate RNA size (Fig. 2A). 
2.2. Synthesis of cRNA and expression i  Xenopus oocytes 
Cardiac ~Z~c subunit mutant (dN60-del1733; c~*lC) (5 /zg) kindly 
obtained from Dr. Birnbaumer, (Los Angeles CA), was linearized with 
HindIII; and rabbit skeletal ~2/5 (5/zg) and ~2/SATMIII (5/lg) were 
linearized with Scal. In vitro transcription was carried out at 37°C for 
120 min in a volume of 50/11 using an in vitro transcription kit (Strat- 
agene), 5 /lg linearized DNA and T7 RNA polymerase (2 units; 
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Boehringer-Mannheim). Complementary RNAs were extracted with 
phenol/chloroform and recovered by ethanol precipitation. The cRNAs 
obtained were dissolved in water and RNA size and amounts were 
determined by RNA gel [23]. Frog oocytes were surgically removed 
from Xenopus laevis ovaries and treated with collagenase (Worthing- 
ton) in calcium-free ND96 buffer for 120 min at 20°C with shaking to 
remove follicular cells. Stage V and VI oocytes were incubated over- 
night in ND 96:96 mM NaC1, 2 mM KCI, 1.8 mM CaCI> 1 mM MgCI2, 
5 mM HEPES pH 7.4, supplemented with 100 units/ml penicillin, 100 
,ug streptomycin and 2.5 mM Na+-pyruvate at 20°C, before RNA 
injection. RNAs were transcribed in vitro using T7 polymerase. 
Oocytes were co-injected with cRNAs of cardiac ~*lC (50 pg/gtl) with 
either skeletal ~2/6 subunit (50 pg//zl) or ~2/~ATMIII (50 ng//ll), in a 
final volume of 50 nl/oocyte using the Drummond microdispenser. 
Oocytes were maintained at 19°C in ND96 buffer, and tested 5 8 days 
after injection. 
2.3. Electrophysiological recordings 
Whole cell Ba 2+ currents were recorded using the two microelectrodes 
voltage clamped (Dagan 8500) on line with IBM compatible PC using 
PCLAMP software version 5.5 (Axon Instruments). Voltage and cur- 
rent agar cushioned electrodes (0.3 0.6 MD tip resistance) filled with 
3 M KC1 were used. The oocytes were impaled in ND96 and inward 
current of 500 ms duration were monitored by voltage steps from - 80 
to + 60 mV, with 30 s intervals, in Ba > buffer: 40 mM Ba(OH)2, 50 mM 
NMDG (N-methyl-D-glucamine), 1 mM KOH, 0.5 mM niflumic acid, and 
5 mM HEPES adjusted to pH 7.4 with methansulphonic acid. Leak and 
capacitance currents were subtracted on-line by P/4 protocol. 
2.4. Generation of GST/o:_, subunit fusion protein and preparation of 
polyclonal antibodies 
An Xba (2675) cDNA fragment of the c~ 2subunit, was filled-in, cut 
with DraI (2160), isolated and subcloned into the bacterial expression 
vector pGEX-KG [24]. The GST/~2 fusion protein, induced by IPTG 
(0.1 M) in TG1 cells (Escherichia coli), was affinity purified on GST- 
agarose according to protocols of the manufacturer. The sequential 
E. eoli lysate extractions generated a fusion protein with minor impuri- 
ties in a Coomassie staining. Two rabbits were repeatedly injected with 
the GST/~2 fusion protein (1 mg/injection i ABM adjuvant). A larger 
fragment, Dral (2160) and Nsil (2798), was subcloned into the bacterial 
expression vector pQE30 (Qiagen). The His6-fusion protein was affinity 
purified on a Ni/NTA agarose according to manufacturer's protocols. 
The antibodies were affinity purified on His6-~2 fusion protein bound 
to Ni/NTA agarose beads according to manufacturer instructions. 
2.5. Preparation of antibodies against the or2 subunit peptide 
Antiserum was raised in two rabbits against a 19 amino acid peptide 
(Lys s°8 IIC 26) of the ~2 subunit conjugated to hemocyanin from key- 
hole limpet hemocyanin (KLH). The peptide is within the alternative 
spliced region and conserved inrat brain, PC 12 cells and skeletal muscle 
[21]. The antibodies were tested for specificity by enzyme linked immu- 
noabsorbant assay (ELISA) and were shown to interact specifically 
with the c~2 subunit in PCI2 cells membranes in a Western analysis. 
2.6. Gel electrophoresis and immunoblotting 
Oocytes (2(~30), preinjected with full-length c~2/~ or the truncated 
form c~2/dATMIII, were homogenized in 150/11 boiling lysis buffer (5% 
mercaptoethanol, 2%sodium dodecyl sulfate, 10% glycerol and 50 mM 
Tris-HCl buffer, pH 6.8) at 100°C for 15 min then spun down at 
100,000 x g for 30 min at 4°C to pellet the yolk platelets and melanin 
pigment, and protein was determined according to Peterson method 
[25]. PC12 cells were solubilized in lysis buffer (see above), centrifuged 
for 10 rain at 10000 x g and the supernatant protein content was deter- 
mined (see above). Proteins were separated on SDS-polyacrylamide g l 
electrophoresis (SDS-PAGE), using mini gel protein apparatus (Bio- 
Rad, Hercules, CA) and than transferred to nitrocellulose using a 
semi-dry electrotransfer apparatus (Pharmacia-LKB-Novablot). The 
blots were incubated with blocking buffer containing 0.02% Tween-20 
and 5% non-fat dry milk in Tris-buffered saline (TBST) overnight, 
followed by affinity purified anti GST/~2 antibodies (see above) in 
blocking buffer for 1 h. After five washes with 0.02% Tween-20 in TBS 
the blot was exposed to peroxidase-conjugated affinity-pure goat anti- 
rabbit IgG (1:10,000) for 1 hr, washed ( x 5) and detected by enhanced 
chemiluminescence detection system (ECL). 
2. 7. Cell growth 
PC 12 Cells were kindly provided by B. Cohen (Berkeley, CA). 
Growth medium consisted of Dulbecco's Modified Eagle's Medium 
(DMEM) with high glucose (Hyclone), supplemented with 10% horse 
serum, 5% fetal calf serum, 130 units/ml penicillin and 0.1 mg/ml strep- 
tomycin. For assays, cells were removed using 1 mM EDTA, replated 
on collagen coated 12-well plates, and assayed 24 h later. 
2.8. [3H]DA release assay 
Transmitter release was determined essentially as previously de- 
scribed [26]. Briefly, cells were incubated for 1.5 h at 37°C with 0.5 ml 
growth medium 0.85 ,ul [3H]DA (41 Ci/mmol) and 10/ag/ml pargyline, 
followed by extensive washings with medium (3 x 0.5 ml) and release 
buffer consisting of (mM): 130 NaC1, 5 KC1, 25 NaHCO 3, 1 Nail 4, 10 
glucose, and 1.8 CaCI 2. In a typical experiment, cells were incubated 
with 0.5 ml buffer for five consecutive incubation periods of 3 min each 
at 37°C. Spontaneous [3H]DA release was measured by collecting the 
medium released by the cells during the two initial 3 min periods. 
Stimulation (60 mM KC1) of release was monitored uring the third 
period. The remaining [3H]DA was extracted from the cells by over- 
night incubation with 0.5 ml of 0.1 N HC1. [3H]DA release during each 
3 min period was expressed as a percentage of the total 3H content of 
the cells. Net evoked release was calculated from [3H]DA released 
during the stimulation period after subtracting basal [3H]DA release in 
the preceding baseline period. 
3. Results 
3.1. Current amplification o[ otl C and ct* 1 C coexpressed with 
ot2/~ subunit 
To characterize current and kinetic alterations of c~l sub- 
unit of the cardiac L-type channel (c~lC) by the c~2/~ sub- 
unit, Xenopus oocytes were preinjected with equimolar 
cRNAs ofc~lC and c~2/~ of rabbit  skeletal muscle. An amplified 
(5-fold) inward current ( -150+30 nA) was observed 
as compared with current mediated by eriC alone (Table 1). 
The mutated ~IC subunit (dN60-del1733; Qin and Birn- 
baumer, personal communicat ion; [27]): designated c~*lC) ex- 
presses a large inward current ( -270  + 60 nA) when expressed 
alone, and an amplified ( -13 fold) current ( -3499 + 244 nA; 
Table 1) when coexpressed with c~2/~ subunit of rabbit skeletal 
muscle. The observed current amplification suggests a strong 
interaction between ~IC  and ~2/& 
Hydropathy plot analysis infers a 3TM orientation for c~2/~ 
[9,10], while a biochemical study predicts a single TM region 
at the ~; subunit with c~2 flanking outside the cell [13]. To 
distinguish between these two models and to better define the 
Table 1 
Amplitude of inward Ca 2+ currents in oocytes preinjected with cRNA 
ofc~l subunit or its mutated form c~* 1C alone, or combined with cRNA 
of the ~2/6 subunit of rabbit skeletal muscle 
Channel subunit Current nA Fold amplification 
c~lC -30_+30 (n=6)  
c~lC/c~2/~ -150 _+ 38 (n = 12) 5 
~*IC -270+60 (n=4)  
~*lC/c~2/b" -3499 + 243 (n = 9) 13 
~*IC/~2ATMIII -180 + 34 (n = 9) none 
~*IC is a deleted carboxyl- and amino-terminal cardiac class L-type 
Ca 2+ channel (dN60-del1733, 27); ~2l~ subunit is the rabbit skeletal 
muscle [10]. 
The data correspond to the mean + S.E.M.; the number of oocytes is 
shown in brackets. Two-sample Student's t-test were carried out assum- 
ing unequal variance. Values of P < 0.001. 
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Fig. 1. Amplification of c~*lC inward currents by ~216 subunit and by a2/6DTMII1, a deleted ~2/6 subunit. (A) Superposition of macroscopic 
whole-cell Ba 2÷ currents mediated by a*lC, ¢t*lC/et2/6 and ~*IC/a2/6zITMIII. Currents are evoked in response to a 500 ms test pulse from a holding 
potential o f -80  mV to +20 mV. (B) Leak subtracted current-voltage r lationship of ~*IC injected alone (o) and in the presence of ~2/6 (e). 
(C) Leak subtracted current-voltage relationship ofc~* 1C expressed alone (o) and in the presence ofa2/6ATMIII (o). Currents were evoked in response 
to a 500 ms pulse from a holding potential of -80 mV to various test potentials at 10 mV increments (as indicated). The data points correspond 
to the mean + S.E.M. (n = 8). 
topology of a functional interaction between the two channel 
subunits, we utilized two different approaches. 
3.2. Current amplification of ct* l C coexpressed with 
ot2/6A TMI I I  subunit 
We deleted a 330 bp fragment at the C-terminal of ~2/6, 
excising about  one-third of the 6 subunit (see section 2), and 
eliminating the third putative t ransmembrane domain. The mu- 
tated ~2/6 subunit, ~2/6ATMIII,  was otherwise identical to 
intact ¢t2/6, including its initiation site and the poly(A) tail (see 
section 2). 
Xenopus oocytes were injected with ~* 1 C, intact or truncated 
et2/6 subunit, and their current properties tested. A superposi- 
tion of ~* 1C current races expressed alone and in the presence 
of intact or truncated ~2/6, clearly demonstrated a large inward 
current amplification by intact ct2/6 and no change in current 
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Fig. 2. RNA gel and Western analysis of intact and truncated ct2/5 subunit (~z2/dATMIII) of voltage-sensitive Ca 2+ channels expressed in Xenopus 
oocytes, cRNAs of full-length and a truncated form of the ~t2/g subunit (1-3470 bp) and intact ~t2/g were injected into defolliculated oocytes and 
after 7 days a crude membrane fraction was prepared and analyzed. (A) RNA gel: RNA markers (lane 1), intact ~2/g (lane 2); and ot2/gATMII! (lane 
3). (B) Western blot analysis: intact ~2/g expressed in Xenopus oocytes (lane 1), truncated ~2/gATMIII subunit expressed in Xenopus oocytes (lane 
2), molecular weight markers (lane 3), uninjected oocytes (lane 4) and PC12 cell-extract (25/~g protein: lane 5) expressed in Xenopus oocytes. 
Antibodies against GST-fusion protein with ~z2 (aa 645 -856). Protein of 7 oocytes could be detected as a distinctive band in 30 s. 
amplitude in oocytes expressing the deleted subunit (Fig. lA). 
Leak subtracted currents at increasing test potentials of ~z*lC 
expressed alone or with intact ~2/~ (Fig. 1B) or ~z2/~ATMIII 
(Fig. 1C) are presented as current-voltage r lationships. Unlike 
intact ~z2/& the truncated form of c~2/~ does not amplify ~z* 1C 
currents and their amplitudes remain similar to those expressed 
by cz*lC alone (Fig. IC). 
3.3. Expression of o~2/5 and ot2/6ATMIII in Xenopus oocytes 
cRNAs of ~216 and c~2/~ATMIil were prepared in vitro (see 
section 2) and analyzed on RNA gel presented in Fig. 2A. Both 
cDNAs and their corresponding cRNAs are detected and their 
expected sizes confirmed. 
Protein expression of intact and truncated cz2/5 subunits was 
tested 6 days after cRNA injection by Western analysis. Two 
types of antibodies were used: one type was generated against 
a GST-~2-fusion protein (Leu 645 Tyr856; see section 2) and the 
other against a 19 amino acid peptide (LysSC~-lle 526) within the 
alternatively spliced region [20-21]. As shown in Fig. 2B, the 
reduced a2/5 is expressed as a 140 kDa protein, identical in size 
to the reduced form of the ~2 subunit present in PC12 cells (Fig. 
2, lane 1 and 5, respectively). However, the expected 2TM 
protein, product of the truncated subunit ~2/6ATMIII, is not 
expressed in oocytes (Fig. 2, lane 2). Instead, a small size band 
recognized by anti ~2 antibodies is detected (Fig. 2, lane 2), 
suggesting that the protein is not properly processed uring 
maturation at the ER and/or onward. This result strongly sup- 
ports a single TM protein which upon deletion of its membrane 
anchorage becomes either stacked at the ER with no destina- 
tion, or a secreted protein. We failed to detect a secreted protein 
encoded by cz2/~ATMIII in the extracellular medium, most 
likely due to its degradtion in the ER. Assuming that the 
subunit is the only membrane-anchor f ~z2, a reduction of 
the S S bond which connects the two parts of intact ~z2/5 
subunit, should release ~z2 free to the extracellular milieu. In- 
deed, ~z2/5- expressing oocytes, treated with 10 mM DTT and 
3 M urea, release free ~z2 (140 kDa protein) into the external 
solution (data not shown, see section 4). 
3.4. The efJeet of anti o~2 peptide antibodies applied 
extracellularly to PC12 cells 
The second approach to establish the topology of ~z2/5 sub- 
unit and distinguish between the two existing models is by 
utilizing specific antibodies against he ~z2 subunit. Antibodies 
were prepared against a GST/~z2 fusion-protein and a 19 amino 
acid peptide (section 2). Both epitopes, display 100% sequence 
homology among rat brain, PC12 cells and rabbit skeletal mus- 
cle [21] (epitope location is shown in Fig. 4). According to a 
3TM model they are located intracellularly, separating two 
putative transmembrane domains residues 422~,45 and 895 
919 [10]. Alternatively, according to a single TM model, the 
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Fig. 3. Inhibition of depolarization i duced [3H]dopamine r lease by 
a2-antibodies in PCI2 cells. Anti ~2 antibodies were externally applied 
to a monolayer of PCI2 cells at the dilution, as indicated, for 90 min 
prior to a 3 min period of KC1 induction (60 mM). Inhibition of KCI 
induced [3H]dopamine r lease by anti cz2 antibodies and preimmune 
serum is presented as percentage of net fractional release (see section 
2). Data is taken from 4 independent experiments using different 
batches of cells. 
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Fig. 4. Alignment of the ot216 polypeptide of voltage-sensitive calcium channel according to current wo models. The three TM model is based 
according to the calculated hydropathy plot [10] and the proposed model of one putative membrane spanning helices is based on results of a 
biochemical experiment [13]. The sequence location of the two epitopes used for generating antibodies, a 19 amino acid peptide within the alternative 
spliced region and a GST-fusion protein, are indicated. 
epitopes are part of a large extracellular mino-terminal region 
[13]. The 19 amino acid peptide, used as an epitope, is located 
next to two deleted segments within the alternative spliced 
region, at a likely functionally diversified omain of the protein 
[20-21]. 
The antiserum raised against he synthetic peptide showed a 
high titer of anti peptide antibodies when assayed in ELISA 
using microtiter plate-bound immunizing peptide as antigen 
(data not shown). They recognized the intact denatured ot2/6 
subunit in a Western blot analysis (Fig. 2). These antibodies 
were externally applied to PC12 cells, and calcium-dependent 
[3H]dopamine secretion was induced by high KC1 (60 mM; see 
section 2). A strong reduction in transmitter release was ob- 
served at 1:15 and 1:10 dilution's as opposed to a significantly 
smaller inhibitory effect observed with pre-immune serum (Fig. 
3). In addition, bradykinin induced [3H]dopamine release in 
PC 12 cells was not affected by anti-co2 antibodies, indicating the 
specific interaction of the antiserum with voltage-dependent 
secretion and excluding non-specific effects of the serum (data 
not shown). 
Antibodies against he GST/~2 fusion protein were not effec- 
tive at inhibiting KCl-evoked transmitter release, in spite of 
their high titer determined in ELISA and similar potency to 
anti-c~2 peptide antibodies in a Western blot analysis (see sec- 
tion 4). 
4. Discussion 
4.1. Modulation of o~*IC by coexpression with intact and 
truncated ~2 subunit 
The pore-forming ~* 1C subunit was coexpressed in Xenopus 
oocytes with intact ~216 or truncated subunit lacking its third 
putative TM domain. Alterations of ~*lC-mediated currents 
by c~2/6 and ~2/6ATMIII were compared. The truncated form 
of the c~216 subunit failed to amplify ~*lC-mediated inward 
current. The deleted fragment (970-1080) consists of the puta- 
tive TMIII and four amino acids placed intracellularly at the 
carboxy-terminal end. Therefore, lack of current amplification 
suggests either that ~2 is no longer present in the membrane or 
a loss of c~2 interaction site with the c~lC subunit. 
4.2. Structural characterization of c~2l~ subunit 
If indeed, the 6-peptide solely anchors ~2 subunit at the 
plasma membrane, c~2/~ATMIII protein should be processed as 
a soluble protein and be either stacked in the ER, or be excreted 
from the cell. In all cases the amplified inward currents hould 
be lost. Alternatively, if the 3TM domain model is correct, a 
110 amino acid shorter protein is expected to be expressed in 
the membrane. A degraded, small size <40 kDa protein is 
detected in a Western blot analysis of oocytes preinjected with 
ot216ATMIII (Fig. 2) but not in the extracellular medium. Most 
likely, an incorrect folded protein is expressed, stacked in the 
ER without a membrane anchor and therefore failing to be 
incorporated into the membrane. 
These results (a) place the c~2 entirely outside the cell and 
(b) outline the topology of a single transmembrane region to 
the 6 subunit schematically presented in Fig. 4 supporting pre- 
vious biochemical study [13]. Furthermore, a secondary struc- 
ture of a single TM protein can better account for the 18 
putative glycosylation sites of ct2/6 placed outside the cell [10]. 
Unlike the fl subunit, that displays pronounced effects on cur- 
rent kinetics [28-30], assigned to the intracellular ~1 loop LI-II 
[30], the ~216 extracellular location restricts its interactions to 
the extracellular domains of the ~1 subunit. 
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4.3. Analogy to insulin receptor and common Ji, atures with 
calcium/polyvalent cation sensing receptor 
The structure of insulin receptor is analogous to cz2/~ subunit 
of voltage-sensitive Ca-,+ channels. The glycosylated single pol- 
ypeptide precursor of the insulin receptor is cleaved into two 
mature polypeptides during its transport hrough the ER to 
Golgi and subsequently to the plasma membrane [31]. The 
mature insulin receptor is composed of two ~z and two fl sub- 
units, where the extracellular ~z subunit is linked to the intracel- 
lular fl subunit by disulfide bonds [31,32]. Under reducing con- 
ditions and in the presence of urea, oocytes expressing intact 
~z2/d subunit released c~2 subunit into the medium (data not 
shown). This experiment, similar to that carried out for the 
insulin receptor [32] further confirms that the S S bond con- 
nects ~2 and ~ subunits, and the g is the cell membrane anchor 
of the ~1 subunit. 
Recently a calcium/polyvalent cation sensing-receptor has 
been cloned and functionally expressed in oocytes and HEK 
cells [33,34]. A typical repeated motif of two adjacent negatively 
charged amino acids was noticed at the large extracellular re- 
gion of the receptor and proposed to be the binding site for 
divalent cations [33,34]. Interestingly, a similar frequency of 
acidic amino acid pairs is apparent at the c~2 sequence, which 
may serve as a divalent cation-binding site at the ~2l~ subunit. 
While the insulin receptor is activated in response to an 
exogenous ignal, additional experiments will be required to 
determine whether ~z2 might interact with an exogenous ligand, 
and divalent cations, which activate calcium/polyvalent cation 
sensing-receptor, would be the potential candidates. 
4.4. cz: antibodies 
Interaction of anti-c~2 antibodies with 0t 1 C was analyzed indi- 
rectly by monitoring depolarization-induced [3H]dopamine r - 
lease. In these cells, depolarization i duced secretion is medi- 
ated by Ca 2+ entry through the L-type Ca 2+ channels (rbC-I 
transcript; [26]). Depolarization i duced [3H]dopamine r lease 
was strongly inhibited in cells pre incubated with anti-c~2 pep- 
tide-serum. On the other hand, bradykinin-induced [3H]dopam- 
ine release in PC12 cells was not affected under identical exper- 
imental conditions, inferring a specific effect of anti-~2 antibod- 
ies on ~IC mediated secretion. The strong inhibition by exter- 
nally applied antibodies determine extracellular topology of the 
c~2 region recognized by anti-c~2-antibodies. Absence of glyco- 
sylation sites in bacteria-processed GST/~z2 fusion-protein 
could account for intact ~z2/g subunit-failing to be recognized 
by anti GST/c~2 antibodies. 
Finally, these results suggest hat possible interaction(s) be- 
tween the pore forming subunit czl, and its largest auxiliary 
subunit ~z2/d, would be restricted to their extracellular domains. 
In addition, furthere xperimentation will be required to evalu- 
ate whether the ~2l~ subunit may play an additionally inde- 
pendent role in regulating depolarization-mediated s cretion. 
In addition, further experimentation will be required to evalu- 
ate whether the ~z216 subunit may play an additionally inde- 
pendent role in regulating depolarization-mediated s cretion. 
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